Name | G-1 |
---|---|
Supplier | Tocris Bioscience |
Catalog | 5446 |
Prices | $189.00, $765.00 |
Sizes | 10 mg, 50 mg |
Function Type | Agonist |
Cas Number | 881639-98-1 |
Chemical Name | (±)-1-[(3aR*,4S*,9bS*)-4-(6-Bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]-ethanone |
Formula | C21H18BrNO3 |
Molecular Weight | 412.28 |
Purity | >98 % |
Description | Potent and selective GPER agonist (K i = 11 nM, EC 50 = 2 nM); displays no activity at ER α and ER β at concentrations up to 10 μ M. Increases cytosolic Ca 2+ and inhibits migration of SKBr3 cells and MCF-7 cells in response to chemoattractants (IC 50 values are 0.7 and 1.6 nM respectively) in vitro . Blocks MCF-1 cell cycle progression at the G 1 phase. Displays therapeutic effects in the mouse EAE model of multiple sclerosis. |
Supplier Page | Shop |
Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, Prossnitz ER, Musti AM, Ando S, Maggiolini M. Cancer Res. 2007 Feb 15;67(4):1859-66.
Blasko E, Haskell CA, Leung S, Gualtieri G, Halks-Miller M, Mahmoudi M, Dennis MK, Prossnitz ER, Karpus WJ, Horuk R. J Neuroimmunol. 2009 Sep 29;214(1-2):67-77.
Ariazi EA, Brailoiu E, Yerrum S, Shupp HA, Slifker MJ, Cunliffe HE, Black MA, Donato AL, Arterburn JB, Oprea TI, Prossnitz ER, Dun NJ, Jordan VC. Cancer Res. 2010 Feb 1;70(3):1184-94.